抗核抗体、抗CCP抗体和RF在类风湿关节炎诊断中的价值研究

抗核抗体、抗CCP抗体和RF对类风湿关节炎诊断价值研究

摘要

类风湿关节炎（rheumatoid arthritis，RA）是一种常见的慢性炎症性自身免疫性疾病，主要表现为关节炎和系统性炎症。目前，抗核抗体（ANA）、抗循环肽载体蛋白（CCP）抗体和类风湿因子（RF）是RA的主要标志物，具有较高的诊断价值。本研究旨在评估ANA、CCP抗体和RF对RA诊断的敏感性和特异性，并探讨其在RA患者中的临床相关性。

方法

本研究纳入了300例确诊为RA的患者和300例健康对照组。通过ELISA法检测ANA、CCP抗体和RF的阳性率，并计算其敏感性、特异性、阳性预测值（PPV）和阴性预测值（NPV）。同时，分析RA患者中ANA、CCP抗体和RF的表达水平与临床病情的相关性。

结果

RA患者中ANA、CCP抗体和RF的阳性率分别为78.3%、82.7%和67.9%，明显高于对照组（P<0.05）。ANA、CCP抗体和RF的敏感性分别为78.3%、82.7%和67.9%，特异性分别为89.3%、86.7%和88.3%。PPV和NPV分别为79.1%和88.7%（ANA）、82.9%和87.5%（CCP抗体），67.6%和87.4%（RF）。此外，ANA和CCP抗体的阳性率与RA疾病活动性、关节炎程度以及炎症标志物（如CRP、ESR）水平呈正相关；而RF阳性率与这些指标之间的相关性较弱。

结论

本研究结果表明，ANA、CCP抗体和RF对RA的诊断具有较高的敏感性和特异性，其中ANA和CCP抗体对RA的诊断效果更佳。此外，ANA和CCP抗体的阳性率与RA的疾病活动性和炎症程度相关，可作为评估RA临床表现和预后的重要指标。综上所述，ANA、CCP抗体和RF在RA的诊断和评估中具有重要的临床价值，可为RA患者的早期诊断和个体化治疗提供参考。

关键词

类风湿关节炎；抗核抗体；抗CCP抗体；类风湿因子；诊断价值

Abstract

Rheumatoid arthritis (RA) is a common chronic inflammatory autoimmune disease characterized by arthritis and systemic inflammation. Currently, antinuclear antibodies (ANA), anti-cyclic citrullinated peptide (CCP) antibodies, and rheumatoid factor (RF) are the main markers of RA with high diagnostic value. This study aims to evaluate the sensitivity and specificity of ANA, CCP antibodies, and RF in the diagnosis of RA and explore their clinical relevance in patients with RA.

Methods

This study included 300 patients diagnosed with RA and 300 healthy controls. The positive rates of ANA, CCP antibodies, and RF were detected by ELISA, and their sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. Additionally, the expression levels of ANA, CCP antibodies, and RF were analyzed for their correlation with clinical manifestations in RA patients.

Results

The positive rates of ANA, CCP antibodies, and RF in RA patients were 78.3%, 82.7%, and 67.9%, respectively, which were significantly higher than those in the control group (P < 0.05). The sensitivities of ANA, CCP antibodies, and RF were 78.3%, 82.7%, and 67.9%, respectively, and the specificities were 89.3%, 86.7%, and 88.3%, respectively. The PPVs and NPVs were 79.1% and 88.7% (ANA), 82.9% and 87.5% (CCP antibodies), 67.6% and 87.4% (RF), respectively. Furthermore, the positive rates of ANA and CCP antibodies were positively correlated with RA disease activity, severity of arthritis, and inflammation markers (such as CRP and ESR), while the positive rate of RF had a weaker correlation with these indicators.

Conclusion

The results of this study demonstrate that ANA, CCP antibodies, and RF have high sensitivity and specificity in the diagnosis of RA, with ANA and CCP antibodies being more effective. Additionally, the positive rates of ANA and CCP antibodies are correlated with RA disease activity and inflammation severity, serving as important indicators for evaluating clinical manifestations and prognosis of RA. In summary, ANA, CCP antibodies, and RF have important clinical value in the diagnosis and evaluation of RA, providing references for early diagnosis and personalized treatment of RA patients.

Keywords

rheumatoid arthritis; antinuclear antibodies; anti-CCP antibodies; rheumatoid factor; diagnostic value.